Exchange: EURONEXT Industry: Medical Devices
0.29% €35.10
America/New_York / 27 sep 2023 @ 11:11
FUNDAMENTALS | |
---|---|
MarketCap: | 154.53 mill |
EPS: | -0.150 |
P/E: | -234.00 |
Earnings Date: | Sep 27, 2023 |
SharesOutstanding: | 4.40 mill |
Avg Daily Volume: | 0.0484 mill |
RATING 2023-10-20 |
---|
B |
Neutral |
RATINGS | ||
---|---|---|
Rating CashFlow: | Neutral | |
Return On Equity: | Strong Sell | |
Return On Asset: | Strong Sell | |
DE: | Strong Buy | |
P/E: | Buy | |
Price To Book: | Sell |
QUARTER GROWTHS | ||||||
---|---|---|---|---|---|---|
2/20 | 4/20 | 2/21 | 4/21 | 2/22 | 4/22 | |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gr.Profit | n/a | n/a | n/a | n/a | n/a | n/a |
Ebit | n/a | n/a | n/a | n/a | n/a | n/a |
Asset | n/a | n/a | n/a | n/a | n/a | n/a |
Debt | n/a | n/a | n/a | n/a | n/a | n/a |
PE RATIO: COMPANY / SECTOR |
---|
0.00x |
Company: PE -234.00 | sector: PE 17.68 |
PE RATIO: COMPANY / INDUSTRY |
---|
-3.89x |
Company: PE -234.00 | industry: PE 60.12 |
DISCOUNTED CASH FLOW VALUE |
---|
N/A |
N/A |
Expected Trading Range (DAY) |
---|
€ 35.02 - 35.18 ( +/- 0.22%) |
ATR Model: 14 days |
Indicator Signals | |
---|---|
RSI 21 | |
SMA | |
Trend | |
Trend 2 | |
Trend 3 | |
MACD |
Volume Signals | |
---|---|
Price | €35.10 (0.29% ) |
Volume | 0.0018 mill |
Avg. Vol. | 0.0484 mill |
% of Avg. Vol | 3.68 % |
Signal 1: | |
Signal 2: |
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Date | Signal | @ | Closed | % |
---|
Biocorp Production designs, develops, and manufactures medical devices and drug delivery systems in France. The company provides Inspair, a smart cap to monitor inhalers and assesses the usage of the device; Mallya, a smart cap for pen injectors that captures injection data; Onejet, a motor driven disposable auto-injector designed to deliver viscosity products; Datapen, a motor driven pen injector; and Injay which collects essential information, such as injection completed, time and date, type of drug, batch number, and expiration date. It also offers pharmaceutical devices, such as NEWGUARD, a safety device compatible with various sizes of prefilled syringes; BIOPASS, a reconstitution system with a needle; and closure systems. The company was incorporated in 2004 and is headquartered in Issoire, France.